Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases

Area of Science:

• Immunology
• Genetics
• Epigenetics

Background:

• Genome-wide association studies (GWAS) have identified genetic variants linked to autoimmune diseases, yet their precise etiology remains unclear.
• Epigenetic mechanisms, such as histone modifications and DNA methylation, are implicated in immune tolerance breakdown and autoreactive responses.
• Emerging evidence suggests the epigenome plays a crucial role in the initiation and perpetuation of autoimmunity.

Purpose of the Study:

• To review current knowledge and future expectations regarding the treatment of autoimmune diseases based on epigenetic aberrations.
• To explore the potential of epigenetic modifications as therapeutic targets in autoimmune conditions.

Main Methods:

• Review of recent experimental and clinical studies on epigenetics in autoimmunity.
• Analysis of data supporting the impact of epigenetic changes in autoimmune diseases.
• Discussion of epigenetic therapy principles and their potential application.

Main Results:

• Epigenetic alterations are significantly associated with autoimmune disease development and progression.
• Mechanistic insights into how epigenetic changes contribute to autoimmunity are accumulating.
• Epigenetic therapies, successful in other fields, show potential for autoimmune disease treatment.

Conclusions:

• The epigenome is a critical factor in understanding and potentially treating autoimmune diseases.
• Targeting epigenetic aberrations represents a promising therapeutic strategy for autoimmune conditions.
• Further research into epigenetic mechanisms and therapies is warranted for autoimmune disease management.